25/08/11 - New Human CYP3A7 Bactosomes

Available with and without cytochrome b5

These bactosomes are human CYP3A7 co-expressed with human P450-reductase in E. coli.

Human CYP3A7 available:


Benefits:

  •     High batch to batch reproducibility
  •     High CYP450 enzymatic levels
  •     Extensive batch characterization : Km, Vmax, Linearity (time & enzyme)
  •     Convenient, standardised packaging

 

Why not take a closer look and discover all human bactosomes available? Follow this link.

 


* Made under licence from BTG International Ltd (AU730155, EP0914446, US6566108 and other patents pending).
United States Patent Nos. 5,420,027 or 5,240,831, Canada Patent No. 2100245 and other patents pending.


 
Previous news Next news
tebu-bio for you


Our offer

Reagents



Lab Services